Quick Answer
Evolv Technologies Holdings, Inc. reported Research And Development Expense of $20.62 million for the year ending 2025.
- Evolv Technologies Holdings, Inc. showed a decrease of -12.1% in Research And Development Expense from 2024 to 2025.
- This data is from Evolv Technologies Holdings, Inc.'s annual report (Form 10-K), filed with the SEC on March 10, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2020: $4.09 million | Q1 2021: $3.74 million | Q2 2021: $1.05 million | Q3 2021: $3.61 million | Q1 2022: $4.18 million | Q2 2022: $4.37 million | Q3 2022: $5.18 million | Q1 2023: $5.40 million | Q2 2023: $6.39 million | Q3 2023: $6.39 million | Q4 2023: $6.30 million | Q1 2024: $6.40 million | Q2 2024: $5.85 million | Q3 2024: $5.81 million | Q4 2024: $5.39 million | Q1 2025: $4.86 million | Q2 2025: $4.74 million | Q3 2025: $5.61 million.
- Over the full 6 years of available data (2020 to 2025), Evolv Technologies Holdings, Inc.'s Research And Development Expense has grown by 31.2%.
- Historical annual values: Fiscal year 2025: $20.62 million | Fiscal year 2024: $23.45 million | Fiscal year 2023: $24.47 million | Fiscal year 2022: $18.54 million | Fiscal year 2021: $11.46 million | Fiscal year 2020: $15.71 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: